annual EBIT:
$139.64M+$142.86M(+4447.57%)Summary
- As of today (May 29, 2025), ADMA annual earnings before interest & taxes is $139.64 million, with the most recent change of +$142.86 million (+4447.57%) on December 31, 2024.
- During the last 3 years, ADMA annual EBIT has risen by +$198.24 million (+338.34%).
- ADMA annual EBIT is now at all-time high.
Performance
ADMA EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
$35.42M-$2.17M(-5.76%)Summary
- As of today (May 29, 2025), ADMA quarterly earnings before interest & taxes is $35.42 million, with the most recent change of -$2.17 million (-5.76%) on March 31, 2025.
- Over the past year, ADMA quarterly EBIT has increased by +$13.26 million (+59.79%).
- ADMA quarterly EBIT is now -11.98% below its all-time high of $40.25 million, reached on September 30, 2024.
Performance
ADMA quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
$152.90M+$13.26M(+9.49%)Summary
- As of today (May 29, 2025), ADMA TTM earnings before interest & taxes is $152.90 million, with the most recent change of +$13.26 million (+9.49%) on March 31, 2025.
- Over the past year, ADMA TTM EBIT has increased by +$133.27 million (+678.87%).
- ADMA TTM EBIT is now at all-time high.
Performance
ADMA TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
ADMA EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +4447.6% | +59.8% | +678.9% |
| 3 y3 years | +338.3% | +263.9% | +335.1% |
| 5 y5 years | +455.5% | +314.3% | +445.3% |
ADMA EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +338.3% | -12.0% | +263.9% | at high | +335.1% |
| 5 y | 5-year | at high | +319.0% | -12.0% | +263.9% | at high | +335.1% |
| alltime | all time | at high | +319.0% | -12.0% | +263.9% | at high | +335.1% |
ADMA EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $35.42M(-5.8%) | $152.90M(+9.5%) |
| Dec 2024 | $139.64M(-4447.6%) | $37.59M(-6.6%) | $139.64M(+54.1%) |
| Sep 2024 | - | $40.25M(+1.5%) | $90.62M(+52.7%) |
| Jun 2024 | - | $39.63M(+78.8%) | $59.34M(+202.3%) |
| Mar 2024 | - | $22.17M(-294.0%) | $19.63M(-711.0%) |
| Dec 2023 | -$3.21M(-93.1%) | -$11.43M(-227.5%) | -$3.21M(-286.6%) |
| Sep 2023 | - | $8.96M(<-9900.0%) | $1.72M(-110.4%) |
| Jun 2023 | - | -$72.00K(-89.3%) | -$16.56M(-35.5%) |
| Mar 2023 | - | -$674.00K(-89.6%) | -$25.68M(-44.9%) |
| Dec 2022 | -$46.63M(-20.4%) | -$6.50M(-30.3%) | -$46.63M(-12.8%) |
| Sep 2022 | - | -$9.32M(+1.4%) | -$53.46M(-8.7%) |
| Jun 2022 | - | -$9.19M(-57.5%) | -$58.56M(-9.9%) |
| Mar 2022 | - | -$21.62M(+62.1%) | -$65.03M(+11.0%) |
| Dec 2021 | -$58.59M(-8.1%) | -$13.33M(-7.5%) | -$58.59M(-4.8%) |
| Sep 2021 | - | -$14.41M(-7.9%) | -$61.56M(+1.0%) |
| Jun 2021 | - | -$15.66M(+3.1%) | -$60.97M(-2.3%) |
| Mar 2021 | - | -$15.18M(-6.8%) | -$62.42M(-2.1%) |
| Dec 2020 | -$63.76M(+62.3%) | -$16.30M(+17.9%) | -$63.76M(+15.3%) |
| Sep 2020 | - | -$13.83M(-19.2%) | -$55.30M(+10.0%) |
| Jun 2020 | - | -$17.11M(+3.5%) | -$50.26M(+13.5%) |
| Mar 2020 | - | -$16.53M(+111.1%) | -$44.29M(+12.7%) |
| Dec 2019 | -$39.29M(-34.8%) | -$7.83M(-10.9%) | -$39.29M(-18.2%) |
| Sep 2019 | - | -$8.79M(-21.1%) | -$48.06M(-9.3%) |
| Jun 2019 | - | -$11.14M(-3.4%) | -$53.00M(-4.1%) |
| Mar 2019 | - | -$11.53M(-30.6%) | -$55.25M(-8.3%) |
| Dec 2018 | -$60.22M(+48.8%) | -$16.60M(+20.9%) | -$60.22M(+8.8%) |
| Sep 2018 | - | -$13.73M(+2.6%) | -$55.36M(-1.2%) |
| Jun 2018 | - | -$13.39M(-18.9%) | -$56.05M(+9.8%) |
| Mar 2018 | - | -$16.50M(+40.5%) | -$51.05M(+26.1%) |
| Dec 2017 | -$40.47M | -$11.74M(-18.6%) | -$40.47M(+23.9%) |
| Sep 2017 | - | -$14.42M(+71.8%) | -$32.66M(+48.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2017 | - | -$8.39M(+41.8%) | -$21.97M(+15.3%) |
| Mar 2017 | - | -$5.92M(+50.6%) | -$19.05M(+10.3%) |
| Dec 2016 | -$17.28M(+7.1%) | -$3.93M(+5.5%) | -$17.28M(-1.1%) |
| Sep 2016 | - | -$3.73M(-31.9%) | -$17.46M(-5.0%) |
| Jun 2016 | - | -$5.47M(+32.1%) | -$18.39M(+7.3%) |
| Mar 2016 | - | -$4.14M(+0.6%) | -$17.14M(+6.3%) |
| Dec 2015 | -$16.13M(+0.3%) | -$4.12M(-11.5%) | -$16.13M(+2.4%) |
| Sep 2015 | - | -$4.65M(+10.1%) | -$15.74M(+11.3%) |
| Jun 2015 | - | -$4.23M(+35.0%) | -$14.14M(+4.5%) |
| Mar 2015 | - | -$3.13M(-16.2%) | -$13.53M(-15.8%) |
| Dec 2014 | -$16.08M(+7.8%) | -$3.73M(+22.4%) | -$16.08M(-4.7%) |
| Sep 2014 | - | -$3.05M(-15.7%) | -$16.88M(+3.2%) |
| Jun 2014 | - | -$3.62M(-36.3%) | -$16.36M(-6.4%) |
| Mar 2014 | - | -$5.68M(+25.2%) | -$17.47M(+17.2%) |
| Dec 2013 | -$14.91M(+89.0%) | -$4.53M(+79.5%) | -$14.91M(+7.1%) |
| Sep 2013 | - | -$2.53M(-46.7%) | -$13.92M(-1.6%) |
| Jun 2013 | - | -$4.74M(+52.2%) | -$14.16M(+33.3%) |
| Mar 2013 | - | -$3.11M(-12.2%) | -$10.62M(+21.9%) |
| Dec 2012 | -$7.89M(>+9900.0%) | -$3.55M(+28.5%) | -$8.72M(+68.3%) |
| Sep 2012 | - | -$2.76M(+129.3%) | -$5.18M(+113.6%) |
| Jun 2012 | - | -$1.20M(-0.2%) | -$2.42M(+96.8%) |
| Mar 2012 | - | -$1.21M(>+9900.0%) | -$1.23M(+3991.7%) |
| Dec 2011 | - | -$8300.00(+59.6%) | -$30.10K(+11.5%) |
| Sep 2011 | - | -$5200.00(-55.6%) | -$27.00K(+2.3%) |
| Jun 2011 | -$26.50K(+29.3%) | -$11.70K(+138.8%) | -$26.40K(+18.4%) |
| Mar 2011 | - | -$4900.00(-5.8%) | -$22.30K(+0.5%) |
| Dec 2010 | - | -$5200.00(+13.0%) | -$22.20K(+4.2%) |
| Sep 2010 | - | -$4600.00(-39.5%) | -$21.30K(+27.5%) |
| Jun 2010 | - | -$7600.00(+58.3%) | -$16.70K(+83.5%) |
| Jun 2010 | -$20.50K | - | - |
| Mar 2010 | - | -$4800.00(+11.6%) | -$9100.00(+111.6%) |
| Dec 2009 | - | -$4300.00 | -$4300.00 |
FAQ
- What is ADMA Biologics annual earnings before interest & taxes?
- What is the all time high annual EBIT for ADMA Biologics?
- What is ADMA Biologics annual EBIT year-on-year change?
- What is ADMA Biologics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for ADMA Biologics?
- What is ADMA Biologics quarterly EBIT year-on-year change?
- What is ADMA Biologics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for ADMA Biologics?
- What is ADMA Biologics TTM EBIT year-on-year change?
What is ADMA Biologics annual earnings before interest & taxes?
The current annual EBIT of ADMA is $139.64M
What is the all time high annual EBIT for ADMA Biologics?
ADMA Biologics all-time high annual earnings before interest & taxes is $139.64M
What is ADMA Biologics annual EBIT year-on-year change?
Over the past year, ADMA annual earnings before interest & taxes has changed by +$142.86M (+4447.57%)
What is ADMA Biologics quarterly earnings before interest & taxes?
The current quarterly EBIT of ADMA is $35.42M
What is the all time high quarterly EBIT for ADMA Biologics?
ADMA Biologics all-time high quarterly earnings before interest & taxes is $40.25M
What is ADMA Biologics quarterly EBIT year-on-year change?
Over the past year, ADMA quarterly earnings before interest & taxes has changed by +$13.26M (+59.79%)
What is ADMA Biologics TTM earnings before interest & taxes?
The current TTM EBIT of ADMA is $152.90M
What is the all time high TTM EBIT for ADMA Biologics?
ADMA Biologics all-time high TTM earnings before interest & taxes is $152.90M
What is ADMA Biologics TTM EBIT year-on-year change?
Over the past year, ADMA TTM earnings before interest & taxes has changed by +$133.27M (+678.87%)